Novo Nordisk on Monday announced a $73 million expansion of its Clayton, North Carolina manufacturing facility to facilitate increased production of the company's diabetes portfolio.
Reference Articles
2 medical companies' expansion to add 241 jobs in North Carolina counties over next 4 years - (Canadian Business)
Novo Nordisk to invest $73m in expansion of U.S. manufacturing facility / expansion to accommodate increased production of insulin delivery devices at Clayton, North Carolina site - (FinanzNachrichten)
Clayton to get 85 new Novo Nordisk jobs - (Triangle Business Journal)
**Published in "First Word"
No comments:
Post a Comment